Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

α-Synuclein (asyn) is a key pathogenetic factor in a group of neurodegenerative diseases generically known as synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although the initial triggers of pathology and progression are...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Sindhu, Armstrong, Sabrina, Hamzeh, Amir, Visanji, Naomi P., Sardi, Sergio Pablo, Tandon, Anurag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124903/
https://www.ncbi.nlm.nih.gov/pubmed/35614915
http://dx.doi.org/10.3389/fneur.2022.852003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124903/
https://www.ncbi.nlm.nih.gov/pubmed/35614915
http://dx.doi.org/10.3389/fneur.2022.852003

Ejemplares similares